Baxter Profit Margin 2006-2018 | BAX

Current and historical gross margin, operating margin and net profit margin for Baxter (BAX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Baxter net profit margin as of December 31, 2018 is 14.27%.
Baxter Annual Profit Margins
Baxter Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $38.973B $11.127B
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $137.198B 26.75
Medtronic (MDT) Ireland $116.492B 17.03
Stryker (SYK) United States $69.834B 24.92
Boston Scientific (BSX) United States $51.351B 24.62
Zimmer Biomet Holdings (ZBH) United States $25.515B 16.33
Smith & Nephew SNATS (SNN) United Kingdom $16.913B 0.00
Canopy Growth (CGC) Canada $16.587B 0.00
ResMed (RMD) United States $14.652B 27.78
Aurora Cannabis (ACB) Canada $9.189B 64.79
Bio-Rad Laboratories (BIO) United States $8.907B 51.09
Perrigo (PRGO) Ireland $6.811B 11.04
Hill-Rom Holdings (HRC) United States $6.475B 20.03
Insulet (PODD) United States $4.964B 1664.00
GW Pharmaceuticals (GWPH) United Kingdom $4.900B 0.00
ICU Medical (ICUI) United States $4.648B 28.79
Haemonetics (HAE) United States $4.345B 38.54
Hutchison China MediTech (HCM) China $3.899B 0.00
Agios Pharmaceuticals (AGIO) United States $3.354B 0.00
NuVasive (NUVA) United States $3.069B 26.66
Neogen (NEOG) United States $3.016B 49.04
Quidel (QDEL) United States $2.490B 22.28
National Vision Holdings (EYE) United States $2.281B 44.86
Aphria (APHA) $1.919B 0.00
HEXO (HEXO) $1.510B 0.00
Phibro Animal Health (PAHC) United States $1.352B 19.44
Cardiovascular Systems (CSII) United States $1.222B 877.50
VAREX IMAGING (VREX) United States $1.214B 23.77
AtriCure (ATRC) United States $1.089B 0.00
Lantheus Holdings (LNTH) United States $0.960B 25.95
Omeros (OMER) United States $0.920B 0.00
PetIQ (PETQ) United States $0.871B 24.92
Cerus (CERS) United States $0.823B 0.00
MacroGenics (MGNX) United States $0.813B 0.00
NanoString Technologies (NSTG) United States $0.787B 0.00
Evolus (EOLS) United States $0.756B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.734B 24.99
TG Therapeutics (TGTX) United States $0.712B 0.00
OraSure Technologies (OSUR) United States $0.591B 25.76
LeMaitre Vascular (LMAT) United States $0.569B 27.03
Surmodics (SRDX) United States $0.567B 82.39
Meridian Bioscience (VIVO) United States $0.550B 16.38
Quanterix (QTRX) United States $0.492B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.320B 0.00
Utah Medical Products (UTMD) United States $0.317B 21.92
Insys Therapeutics (INSY) United States $0.314B 0.00
BioLife Solutions (BLFS) United States $0.308B 127.08
Vapotherm (VAPO) United States $0.293B 0.00
Rockwell Medical (RMTI) United States $0.267B 0.00
Cytosorbents (CTSO) United States $0.229B 0.00
Owens & Minor (OMI) United States $0.216B 2.96
Zynex (ZYXI) United States $0.174B 18.59
Bovie Medical (APYX) United States $0.161B 0.00
Fonar (FONR) United States $0.130B 6.96
Chimerix (CMRX) United States $0.129B 0.00
Chembio Diagnostics (CEMI) United States $0.125B 0.00
Surface Oncology (SURF) United States $0.112B 0.00
United-Guardian (UG) United States $0.089B 20.32
InfuSystems Holdings (INFU) United States $0.086B 0.00
Female Health (VERU) United States $0.085B 0.00
Neurotrope (NTRP) United States $0.076B 0.00
Trinity Biotech (TRIB) Ireland $0.067B 19.79
Oramed Pharmaceuticals (ORMP) United States $0.066B 0.00
ImmuCell (ICCC) United States $0.046B 0.00
GUARDION HEALTH (GHSI) United States $0.045B 0.00
Senestech (SNES) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.023B 0.00
Myomo (MYO) United States $0.020B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.006B 5.87